VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
NMRANeumora Therapeutics, Inc. Common Stock$1.78$330M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNMRAPrice History

NMRA logoNeumora Therapeutics, Inc. Common Stock (NMRA) Stock Price History

Historical prices from 2023 to 2026

$1.78+0.00  (+0.00%)close Jun 12
Returns
1M
-6.3%
3M
-43.3%
YTD
+7.2%
1Y
+98.3%
3Y
-52.2%
5Y
-35.7%
ATH$21.00Mar 2024-91.5%
ATL$0.61May 2025pre-split
Avg Vol (50D)1.2M/ day
52-Week Range$0.72 — $3.65
LowCurrent: $1.78High

Loading 10-year price history...

NMRA Historical Performance

1 YearTotal Return
+98.3%
Price: +98.3%
3 YearsTotal Return
-89.0%
CAGR: -52.2%
Price: -89.0%
5 YearsTotal Return
-89.0%
CAGR: -35.7%
Price: -89.0%
YTD
+7.2%

NMRA Annual Returns

Year-by-year price performance · 2023–2026

Best+4.9%2023
Worst-37.3%2024
Up years2/4
2023+4.9%
2024-37.3%
2025-9.1%
2026+110.2%
2023 annual price return
+4.9%
2024 annual price return
-37.3%
2025 annual price return
-9.1%
2026 annual price return
+110.2%
LessMore
Alpha vs S&P 500
1Y+75.4%
3Y-71.7%
5Y-47.5%

Price returns only.

Download Historical Data

689 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

NMRA Stock Price Trajectory (2023–2026)

As of June 13, 2026, Neumora Therapeutics, Inc. Common Stock (NMRA) trades at $1.78, representing a +98.3% return over the past year. The stock has delivered a -89.0% total return over five years (-35.7% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $21.00 on March 8, 2024. From this peak, NMRA has corrected -91.5%, currently trading 19% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers ACAD (-3.0% 1Y), INVA (+6.3% 1Y), and AXSM (+140.2% 1Y), NMRA has underperformed the peer group average. Compare NMRA vs ACAD →

NMRA Historical Price Data · from 2023

Rows 1–50 of 689
Date Open High Low Close Volume Change %
2026-06-121.781.841.761.78719K0.00%
2026-06-111.651.841.631.781.14M+11.25%
2026-06-101.611.671.571.60667K-3.03%
2026-06-091.631.701.601.65743K+1.85%
2026-06-081.681.711.601.62598K-0.61%
2026-06-051.721.731.611.63847K-6.86%
2026-06-041.741.781.731.75684K+0.57%
2026-06-031.741.751.701.74646K-0.57%
2026-06-021.831.831.731.75838K-3.85%
2026-06-011.851.891.781.82793K-1.62%
2026-05-291.891.961.851.85891K-1.60%
2026-05-281.841.931.821.881.28M+1.08%
2026-05-271.831.911.801.86702K+1.09%
2026-05-261.911.931.801.841.29M-0.54%
2026-05-221.851.981.821.851.36M0.00%
2026-05-211.711.901.661.851.59M+7.56%
2026-05-201.701.781.681.721.07M+2.99%
2026-05-191.761.791.671.671.00M-5.65%
2026-05-181.841.871.741.77830K-3.80%
2026-05-151.941.961.831.84816K-6.60%
2026-05-141.791.991.781.971.36M+10.67%
2026-05-131.901.901.751.781.77M-6.32%
2026-05-121.871.951.851.90813K+1.60%
2026-05-111.851.891.741.871.46M+2.19%
2026-05-081.971.981.751.832.10M-5.67%
2026-05-072.352.361.911.942.74M-16.74%
2026-05-062.322.422.272.331.69M+1.30%
2026-05-052.362.402.232.30248K-0.43%
2026-05-042.442.482.292.311.23M-5.33%
2026-05-012.472.552.332.443.50M-1.21%
2026-04-302.292.502.232.471.20M+9.78%
2026-04-292.242.372.202.251.14M0.00%
2026-04-282.222.292.162.252.05M+1.35%
2026-04-272.252.312.182.22942K-1.33%
2026-04-242.232.262.152.25810K+0.90%
2026-04-232.302.312.192.231.18M-3.46%
2026-04-222.422.462.262.311.57M-0.43%
2026-04-212.202.412.092.321.84M+5.94%
2026-04-202.122.312.072.191.96M+1.86%
2026-04-172.042.191.992.151.42M+7.50%
2026-04-162.072.071.962.00666K-2.91%
2026-04-152.032.101.992.061.10M+1.48%
2026-04-142.082.171.992.032.10M-1.46%
2026-04-132.052.212.022.06912K+0.98%
2026-04-102.092.142.002.04764K-1.92%
2026-04-092.162.162.052.08841K-4.59%
2026-04-082.212.242.152.181.15M+2.35%
2026-04-072.112.192.042.131.28M+0.47%
2026-04-061.992.151.972.121.71M+6.00%
2026-04-022.022.101.992.001.24M-4.31%
…

What if you invested $1,000 in NMRA 10 years ago?

Total return calculator · dividends reinvested

Calculate Returns

How much would $100/month in NMRA be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is NMRA Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

NMRA vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

NMRA — Frequently Asked Questions

Quick answers to the most common questions about buying NMRA stock.

How has NMRA stock performed recently?

NMRA returned +98.3% over the past year, beating its 5-year annualized CAGR of -35.7%. The stock trades below its 200-day moving average, confirming the uptrend.

What is NMRA's all-time high price?

Neumora Therapeutics, Inc. Common Stock reached $21.00 on 2024-03-08. The 52-week high is $3.65. Current 1-year return of +98.3% places the stock closer to historical peaks.

Where can I download NMRA historical price data?

This page provides NMRA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2023-2026, downloadable in CSV format.

345 data points · sampled from 689